Mutations in HNF1A Result in Marked Alterations of Plasma Glycan Profile

Citation for published version: Thanabalasingham, G, Huffman, JE, Kattla, JJ, Novokmet, M, Rudan, I, Gloyn, AL, Hayward, C, Adamczyk, B, Reynolds, RM, Muzinic, A, Hassanali, N, Pucic, M, Bennett, AJ, Essafi, A, Polasek, O, Mughal, SA, Redzic, I, Primorac, D, Zgaga, L, Kolcic, I, Hansen, T, Gasperikova, D, Tjora, E, Strachan, MWJ, Nielsen, T, Stanik, J, Klimes, I, Pedersen, OB, Njølstad, PR, Wild, SH, Gyllensten, U, Gornik, O, Wilson, JF, Hastie, ND, Campbell, H, McCarthy, MI, Rudd, PM, Owen, KR, Lauc, G & Wright, AF 2013, 'Mutations in HNF1A Result in Marked Alterations of Plasma Glycan Profile' Diabetes , vol. 62, no. 4, pp. 1329-1337. DOI: 10.2337/db12-0880

Mark I. McCarthy | Pauline M. Rudd | Igor Rudan | Jennifer E. Huffman | Harry Campbell | Torben Hansen | Ulf Gyllensten | Caroline Hayward | Lina Zgaga | Mark W. J. Strachan | Alan F. Wright | Dragan Primorac | Ozren Polasek | Gordan Lauc | Anna L. Gloyn | Barbara Adamczyk | Olga Gornik | Iwar Klimes | Pål R. Njølstad | Jayesh J. Kattla | Mislav Novokmet | Irma Redzic | Ivana Kolcic | Trine Nielsen | M. McCarthy | T. Nielsen | T. Hansen | O. Pedersen | S. Wild | N. Hastie | K. Owen | I. Rudan | A. Wright | A. Gloyn | P. Njølstad | A. Bennett | N. Hassanali | C. Hayward | I. Kolčić | O. Polašek | H. Campbell | James F. Wilson | D. Gašperíková | J. Stanik | U. Gyllensten | L. Zgaga | I. Klimeš | B. Adamczyk | Abdelkader Essafi | P. Rudd | J. Huffman | D. Primorac | R. Reynolds | T. Hansen | E. Tjora | G. Lauc | M. Strachan | O. Gornik | M. Pučić | Irma Redžić | M. Novokmet | Sarah H. Wild | Amanda J. Bennett | Neelam Hassanali | Rebecca M. Reynolds | G. Thanabalasingham | Nicholas D. Hastie | A. Mužinić | Erling Tjora | Daniela Gasperikova | Katharine R. Owen | Gaya Thanabalasingham | Ana Muzinic | Maja Pucic | Saima A. Mughal | Juraj Stanik | Oluf B. Pedersen | Abdelkader Essa | J. Kattla | S. Mughal | A. Essa | U. Gyllensten | James F. Wilson | M. McCarthy | A. Wright | Igor Rudan | Alan F. Wright | T. Hansen | Oluf Pedersen | Nick Hastie | Harry Campbell | Iwar Klimeš | M. McCarthy | Pauline M. Rudd | M. Strachan | Pål R. Njølstad | Sarah H Wild | Rebecca M. Reynolds

[1]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[2]  M. McCarthy,et al.  Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young , 2012, Diabetes Care.

[3]  David J. Harvey,et al.  HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. , 2008, Analytical biochemistry.

[4]  B. Shields,et al.  High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes , 2011, Diabetes Care.

[5]  Y. Matsuzawa,et al.  Three new mutations in the hepatocyte nuclear factor-1α gene in Japanese subjects with diabetes mellitus: clinical features and functional characterization , 1999, Diabetologia.

[6]  P. Bingley,et al.  Islet autoantibodies can discriminate maturity‐onset diabetes of the young (MODY) from Type 1 diabetes , 2011, Diabetic medicine : a journal of the British Diabetic Association.

[7]  R. Dwek,et al.  Changes of serum glycans during sepsis and acute pancreatitis. , 2007, Glycobiology.

[8]  P. Bork,et al.  A method and server for predicting damaging missense mutations , 2010, Nature Methods.

[9]  B. Shields,et al.  Maturity-onset diabetes of the young (MODY): how many cases are we missing? , 2010, Diabetologia.

[10]  G. Lauc,et al.  Stability of N-glycan profiles in human plasma. , 2009, Glycobiology.

[11]  D. Santini,et al.  The biosynthesis of the selectin-ligand sialyl Lewis x in colorectal cancer tissues is regulated by fucosyltransferase VI and can be inhibited by an RNA interference-based approach. , 2011, The international journal of biochemistry & cell biology.

[12]  I. Rudan,et al.  Variability, heritability and environmental determinants of human plasma N-glycome. , 2009, Journal of proteome research.

[13]  B. Shields,et al.  Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes , 2011, Diabetes Care.

[14]  C. Bellanné-Chantelot,et al.  The Type and the Position of HNF1A Mutation Modulate Age at Diagnosis of Diabetes in Patients with Maturity-Onset Diabetes of the Young (MODY)-3 , 2008, Diabetes.

[15]  Louise Royle,et al.  Proposal for a standard system for drawing structural diagrams of N‐ and O‐linked carbohydrates and related compounds , 2009, Proteomics.

[16]  K. Owen,et al.  Diagnosis and management of maturity onset diabetes of the young (MODY) , 2011, BMJ : British Medical Journal.

[17]  J. Skupień,et al.  Clinical Application of 1,5-Anhydroglucitol Measurements in Patients with Hepatocyte Nuclear Factor-1α Maturity-Onset Diabetes of the Young , 2008, Diabetes Care.

[18]  R Apweiler,et al.  On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. , 1999, Biochimica et biophysica acta.

[19]  A. Hattersley,et al.  The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria. , 2001, Diabetes.

[20]  J. Skupień,et al.  Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY. , 2007, The review of diabetic studies : RDS.

[21]  S. Ellard,et al.  Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity‐onset diabetes of the young , 2006, Human mutation.

[22]  L. Groop,et al.  An investigation of serum concentration of apoM as a potential MODY3 marker using a novel ELISA , 2010, Journal of internal medicine.

[23]  S. Ellard,et al.  Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young , 2008, Diabetologia.

[24]  A. Brown,et al.  Serum amino acids in patients with mutations in the hepatocyte nuclear factor‐1 alpha gene , 2004, Diabetic medicine : a journal of the British Diabetic Association.

[25]  S. Henikoff,et al.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm , 2009, Nature Protocols.

[26]  M. McCarthy,et al.  A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes , 2011, Diabetologia.

[27]  C. Sander,et al.  Predicting the functional impact of protein mutations: application to cancer genomics , 2011, Nucleic acids research.

[28]  P. Boutin,et al.  Anatomy of a Homeoprotein Revealed by the Analysis of Human MODY3 Mutations* , 1999, The Journal of Biological Chemistry.

[29]  B. Shields,et al.  A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin‐treated patients , 2009, Diabetic medicine : a journal of the British Diabetic Association.

[30]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[31]  I. Rudan,et al.  Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. , 2010, Glycobiology.

[32]  Wei Wang,et al.  Genomics Meets Glycomics—The First GWAS Study of Human N-Glycome Identifies HNF1α as a Master Regulator of Plasma Protein Fucosylation , 2010, PLoS genetics.

[33]  A. Hattersley,et al.  Genetic cause of hyperglycaemia and response to treatment in diabetes , 2003, The Lancet.

[34]  Richard D. Cummings,et al.  The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.

[35]  M. McCarthy,et al.  Evaluation of Serum 1,5 Anhydroglucitol Levels as a Clinical Test to Differentiate Subtypes of Diabetes , 2010, Diabetes Care.

[36]  A. Hattersley,et al.  Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. , 2003, Diabetes.

[37]  A. Hattersley,et al.  Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes. , 2006, Human molecular genetics.

[38]  M. McCarthy,et al.  Assessment of High-Sensitivity C-Reactive Protein Levels as Diagnostic Discriminator of Maturity-Onset Diabetes of the Young Due to HNF1A Mutations , 2010, Diabetes Care.

[39]  J. Copas,et al.  Overestimation of the receiver operating characteristic curve for logistic regression , 2002 .